Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 29 (Search time: 0.002 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
1-Oct-2012Conservation of functional sites on interleukin-6 and implications for evolution of signalling complex assembly and therapeutic intervention.Veverka, V; Baker, T; Redpath, NT; Carrington, B; Muskett, FW; Taylor, RJ; Lawson, AD; Henry, AJ; Carr, MDJournal Article
14-Aug-2001High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factorsLemercinier, X; Cheeseman, B; McIntosh, PB; Muskett, FW; Carr, MD; Thim, L; Carr, MDJournal Article
Dec-2009(15)N, (13)C and (1)H resonance assignments and secondary structure determination of the Mycobacterium tuberculosis Rv0287-Rv0288 protein complex.Ilghari, D; Waters, LC; Veverka, V; Muskett, FW; Carr, MDJournal Article
12-Oct-2012Structural, biochemical, and functional characterization of the cyclic nucleotide binding homology domain from the mouse EAG1 potassium channelMarques-Carvalho, MJ; Vieira-Pires, RS; Morais-Cabral, JH; Marques-Carvalho, MJ; Sahoo, N; Schönherr, R; Muskett, FW; Gabant, G; Cadene, MJournal Article
20-Jul-2005Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6.Renshaw, PS; Lightbody, KL; Veverka, V; Muskett, FW; Kelly, G; Frenkiel, TA; Gordon, SV; Hewinson, RG; Burke, B; Norman, J; Williamson, RA; Carr, MDJournal Article
17-Apr-2009Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.Veverka, V; Henry, AJ; Slocombe, PM; Ventom, A; Mulloy, B; Muskett, FW; Muzylak, M; Greenslade, K; Moore, A; Zhang, L; Gong, J; Qian, X; Paszty, C; Taylor, RJ; Robinson, MK; Carr, MDJournal Article
13-Nov-2009High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.Wilkinson, IC; Hall, CJ; Veverka, V; Shi, JY; Muskett, FW; Stephens, PE; Taylor, RJ; Henry, AJ; Carr, MDJournal Article
2006NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4.Waters, LC; Böhm, M; Veverka, V; Muskett, FW; Frenkiel, TA; Kelly, GP; Prescott, A; Dosanjh, NS; Klempnauer, KH; Carr, MDJournal Article
2001Sequence-specific assignment and determination of the secondary structure of the 163-residue M. tuberculosis and M. bovis antigenic protein mpb70 [3]Bloemink, MJ; Kemmink, J; Dentten, E; Muskett, FW; Whelan, A; Sheikh, A; Hewinson, G; Williamson, RA; Carr, MDJournal Article
24-Jan-2008Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.Veverka, V; Crabbe, T; Bird, I; Lennie, G; Muskett, FW; Taylor, RJ; Carr, MDJournal Article